Applying Mode-of-Action and Pharmacokinetic Considerations in Contemporary Cancer Risk Assessments: An Example with Trichloroethylene
暂无分享,去创建一个
[1] Lock Ea. Studies on the mechanism of nephrotoxicity and nephrocarcinogenicity of halogenated alkenes. , 1988 .
[2] C. Mitoma,et al. Metabolic disposition study of chlorinated hydrocarbons in rats and mice. , 1985, Drug and chemical toxicology.
[3] D. Hathway. Consideration of the evidence for mechanisms of 1,1,2-trichloroethylene metabolism, including new identification of its dichloroacetic acid and trichloroacetic acid metabolites in mice. , 1980, Cancer letters.
[4] J. Foster,et al. Trichloroethylene-induced mouse lung tumors: studies of the mode of action and comparisons between species. , 1997, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[5] D Hattis,et al. Uncertainties in pharmacokinetic modeling for perchloroethylene. I. Comparison of model structure, parameters, and predictions for low-dose metabolism rates for models derived by different authors. , 1990, Risk analysis : an official publication of the Society for Risk Analysis.
[6] W. Dekant,et al. Metabolism of trichloroethene--in vivo and in vitro evidence for activation by glutathione conjugation. , 1990, Chemico-biological interactions.
[7] M. A. Pereira,et al. The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. , 1987, Toxicology and applied pharmacology.
[8] T. Goldsworthy,et al. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid. , 1992, Carcinogenesis.
[9] L. Lash,et al. Purification and characterization of human kidney cytosolic cysteine conjugate beta-lyase activity. , 1990, Drug metabolism and disposition: the biological fate of chemicals.
[10] G. Olson,et al. Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse☆ , 1992 .
[11] J. Fuscoe,et al. In vivo genotoxicity of dichloroacetic acid: Evaluation with the mouse peripheral blood micronucleus assay and the single cell gel assay , 1996, Environmental and molecular mutagenesis.
[12] O. Raaschou-Nielsen,et al. Cancer Incidence Among Danish Workers Exposed to Trichloroethylene , 2001, Journal of occupational and environmental medicine.
[13] R. Bull. Carcinogenic and mutagenic properties of chemicals in drinking water. , 1985, The Science of the total environment.
[14] B C Allen,et al. Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.
[15] Michael A. Pereira. Carcinogenic Activity of Dichloroacetic Acid and Trichloroacetic Acid in the Liver of Female B6C3F1 Mice , 1996 .
[16] R. Cattley,et al. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. , 1988, Cancer research.
[17] D. Stevens,et al. Metabolism of bromodichloroacetate in B6C3F1 mice. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[18] G. Olson,et al. Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[19] J. Lipscomb,et al. Glutathione conjugation of trichloroethylene in human liver and kidney: kinetics and individual variation. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[20] D Hattis,et al. Uncertainties in pharmacokinetic modeling for perchloroethylene: II. Comparison of model predictions with data for a variety of different parameters. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.
[21] S. Ohmori,et al. Metabolism of trichloroethylene. , 1980, Biochemical pharmacology.
[22] M. A. Pereira,et al. Promotion by mixtures of dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice. , 1997, Cancer letters.
[23] H J Clewell,et al. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. , 2000, Environmental health perspectives.
[24] B. Thrall,et al. Contribution of dichloroacetate and trichloroacetate to liver tumor induction in mice by trichloroethylene. , 2002, Toxicology and applied pharmacology.
[25] M. Abdel‐Rahman,et al. Toxicity and metabolism of trichloroethylene in rat hepatocytes , 1989, Archives of environmental contamination and toxicology.
[26] M. Andersen,et al. Physiologically based pharmacokinetic analyses of simple mixtures. , 1994, Environmental health perspectives.
[27] W. Stott. Chemically induced proliferation of peroxisomes: implications for risk assessment. , 1988, Regulatory toxicology and pharmacology : RTP.
[28] M E Andersen,et al. Dioxin hepatic carcinogenesis: biologically motivated modeling and risk assessment. , 1993, Toxicology letters.
[29] C J Portier,et al. Variability of safe dose estimates when using complicated models of the carcinogenic process. A case study: methylene chloride. , 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[30] A. Deangelo,et al. Analysis of DNA strand breaks induced in rodent liver in vivo, hepatocytes in primary culture, and a human cell line by chlorinated acetic acids and chlorinated acetaldehydes , 1992, Environmental and molecular mutagenesis.
[31] Reddy Jk,et al. Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans , 1983 .
[32] M. W. Anders,et al. Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other alpha-haloacids. , 1998, Chemical research in toxicology.
[33] J. H. Carter,et al. Biochemical, pathologic and morphometric alterations induced in male B6C3F1 mouse liver by short-term exposure to dichloroacetic acid. , 1995, Toxicology letters.
[34] K. Griffin,et al. Peroxisome proliferator activated receptor-alpha expression in human liver. , 1998, Molecular pharmacology.
[35] W. Dekant,et al. Renal cell cancer correlated with occupational exposure to trichloroethene , 1998, Journal of Cancer Research and Clinical Oncology.
[36] J. Popp,et al. Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[37] J. Groopman,et al. Molecular Dosimetry and Human Cancer: Analytical, Epidemiological, and Social Considerations , 1991 .
[38] M. Andersen,et al. Negative selection in hepatic tumor promotion in relation to cancer risk assessment. , 1995, Toxicology.
[39] L. Gold,et al. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points. , 1997, Regulatory toxicology and pharmacology : RTP.
[40] P. G. Wells,et al. Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans , 1980, Diabetologia.
[41] D. Henschler,et al. Trichloroethylene exposure and trichloroethylene metabolites in urine and blood , 2004, Archiv für Toxikologie.
[42] T. Nakajima,et al. Morphological and biochemical analyses of trichloroethylene hepatotoxicity: differences in ethanol- and phenobarbital-pretreated rats. , 1991, Toxicology and applied pharmacology.
[43] L. Tuxen,et al. Integrated risk information system (IRIS) , 1990 .
[44] R H Reitz,et al. In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models. , 1989, Toxicology and applied pharmacology.
[45] J. Opdam,et al. A method for the retrospective estimation of the individual respiratory intake of a highly and a poorly metabolising solvent during rest and physical exercise. , 1989, British journal of industrial medicine.
[46] T. Nakajima,et al. A pharmacokinetic model to study the excretion of trichloroethylene and its metabolites after an inhalation exposure. , 1977, British journal of industrial medicine.
[47] F. Korte,et al. Comparative metabolism of [14C] trichloroethylene in chimpanzees, baboons, and rhesus monkeys , 1982 .
[48] J. Powell,et al. The excretion of sodium trichloracetate. , 1945, The Journal of pharmacology and experimental therapeutics.
[49] H. Yamazaki,et al. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. , 1994, The Journal of pharmacology and experimental therapeutics.
[50] T. Brüning,et al. Acute intoxication with trichloroethene: clinical symptoms, toxicokinetics, metabolism, and development of biochemical parameters for renal damage. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.
[51] M. Andersen,et al. Risk Assessment Extrapolations and Physiological Modeling , 1985, Toxicology and industrial health.
[52] H. Vainio,et al. Sex-, age- and pregnancy-induced changes in the metabolism of toluene and trichloroethylene in rat liver in relation to the regulation of cytochrome P450IIE1 and P450IIC11 content. , 1992, The Journal of pharmacology and experimental therapeutics.
[53] Adduction of hemoglobin and albumin in vivo by metabolites of trichloroethylene, trichloroacetate, and dichloroacetate in rats and mice. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[54] B. L. Duuren,et al. Carcinogenicity of halogenated olefinic and aliphatic hydrocarbons in mice. , 1979, Journal of the National Cancer Institute.
[55] R. Bull,et al. Early induction of reparative hyperplasia in the liver of B6C3F1 mice treated with dichloroacetate and trichloroacetate. , 1990, Toxicology.
[56] P. Åstrand,et al. Textbook of Work Physiology , 1970 .
[57] Dale Hattis,et al. Improvements in Quantitative Noncancer Risk Assessment , 1993 .
[58] B C Allen,et al. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.
[59] L. Lash,et al. Metabolic activation and detoxication of nephrotoxic cysteine and homocysteine S-conjugates. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[60] Thomas Brüning,et al. Renal cell cancer risk and occupational exposure to trichloroethylene: results of a consecutive case-control study in Arnsberg, Germany. , 2003, American journal of industrial medicine.
[61] R. Jirtle,et al. Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation. , 1991, Progress in clinical and biological research.
[62] T. Goldsworthy,et al. Potential role of alpha-2 mu-globulin, protein droplet accumulation, and cell replication in the renal carcinogenicity of rats exposed to trichloroethylene, perchloroethylene, and pentachloroethane. , 1988, Toxicology and applied pharmacology.
[63] K S Crump,et al. An improved procedure for low-dose carcinogenic risk assessment from animal data. , 1984, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[64] F. A. Smith,et al. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.
[65] H. Barton,et al. Dichloroacetic acid: metabolism in cytosol. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[66] R. Bull,et al. Induction of strand breaks in DNA by trichloroethylene and metabolites in rat and mouse liver in vivo. , 1988, Toxicology and applied pharmacology.
[67] R. Maronpot,et al. ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1 mice. , 1994, Carcinogenesis.
[68] J W Fisher,et al. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. , 1998, Toxicology and applied pharmacology.
[69] J. Fisher,et al. Identification of S-(1,2-dichlorovinyl)glutathione in the blood of human volunteers exposed to trichloroethylene. , 1999, Journal of toxicology and environmental health. Part A.
[70] J. Mills,et al. Effect of cadmium on F-actin and microtubules of Madin-Darby canine kidney cells. , 1989, Toxicology and applied pharmacology.
[71] I. Schultz,et al. Pharmacokinetics and metabolism of dichloroacetate in the F344 rat after prior administration in drinking water. , 1997, Toxicology and applied pharmacology.
[72] H. Bolt,et al. Reactive metabolites and carcinogenicity of halogenated ethylenes. , 1982, Biochemical pharmacology.
[73] G. Olson,et al. Failure of monochloroacetic acid and trichloroacetic acid administered in the drinking water to produce liver cancer in male F344/N rats. , 1997, Journal of toxicology and environmental health.
[74] J. Högberg,et al. Three industrial solvents investigated for tumor promoting activity in the rat liver. , 1987, Cancer letters.
[75] M. W. Anders,et al. Mechanism of S-(1,2-dichlorovinyl)glutathione-induced nephrotoxicity. , 1986, Biochemical pharmacology.
[76] D. Putt,et al. Glutathione conjugation of trichloroethylene in rats and mice: sex-, species-, and tissue-dependent differences. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[77] D. House,et al. Hepatocarcinogenicity in the male B6C3F1 mouse following a lifetime exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action. , 1999, Journal of toxicology and environmental health. Part A.
[78] Dedrick Rl,et al. Pharmacokinetic and pharmacodynamic considerations for chronic hemodialysis. , 1975, Kidney international. Supplement.
[79] P A Stewart,et al. Retrospective cohort mortality study of workers at an aircraft maintenance facility. II. Exposures and their assessment. , 1991, British journal of industrial medicine.
[80] A. Koizumi. Potential of physiologically based pharmacokinetics to amalgamate kinetic data of trichloroethylene and tetrachloroethylene obtained in rats and man. , 1989, British journal of industrial medicine.
[81] B. Thrall,et al. Dichloroacetate stimulates glycogen accumulation in primary hepatocytes through an insulin-independent mechanism. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[82] J. Larson,et al. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. , 1992, Toxicology and applied pharmacology.
[83] D W Potter,et al. A physiologically based pharmacokinetic and pharmacodynamic model to describe the oral dosing of rats with ethyl acrylate and its implications for risk assessment. , 1992, Toxicology and applied pharmacology.
[84] A. Owens,et al. Further studies on the metabolic fate of chloral hydrate and trichloroethanol. , 1955, Bulletin of the Johns Hopkins Hospital.
[85] R J Bull,et al. Physiologically-based pharmacokinetic model for trichloroethylene considering enterohepatic recirculation of major metabolites. , 1998, Risk analysis : an official publication of the Society for Risk Analysis.
[86] P A Stewart,et al. Retrospective cohort mortality study of workers at an aircraft maintenance facility. I. Epidemiological results. , 1991, British journal of industrial medicine.
[87] K. Nomiyama,et al. Dose-response relationship for trichloroethylene in man , 1977, International archives of occupational and environmental health.
[88] J. Boice,et al. Mortality among aircraft manufacturing workers. , 1999, Occupational and environmental medicine.
[89] Jack A. Taylor,et al. Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. , 1994, Pharmacogenetics.
[90] B. Merrick,et al. Differing hepatotoxicity and lethality after subacute trichloroethylene exposure in aqueous or corn oil gavage vehicles in B6C3F1 Mice , 1989, Journal of applied toxicology : JAT.
[91] J. Peters,et al. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. , 1997, Carcinogenesis.
[92] J. Manson,et al. Effects of oral exposure to trichloroethylene on female reproductive function. , 1984, Toxicology.
[93] M. Templin,et al. The role of dichloroacetate in the hepatocarcinogenicity of trichloroethylene. , 1993, Toxicology letters.
[94] R. T. Miller,et al. Relationship of peroxisome proliferator-induced cellular effects to hepatocarcinogenesis. , 1994, Progress in clinical and biological research.
[95] H J Clewell,et al. Biologically motivated models for chemical risk assessment. , 1989, Health physics.
[96] G. Williams,et al. Saccharin mechanistic data and risk assessment: urine composition, enhanced cell proliferation, and tumor promotion. , 1996, Pharmacology & therapeutics.
[97] R. Conolly,et al. A 90-day chloroform inhalation study in female and male B6C3F1 mice: implications for cancer risk assessment. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[98] M. Templin,et al. Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. , 1993, Toxicology and applied pharmacology.
[99] D Henschler,et al. Nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L-cysteine is a urinary metabolite after occupational 1,1,2-trichloroethene exposure in humans: implications for the risk of trichloroethene exposure. , 1993, Environmental health perspectives.
[100] B. Lake,et al. Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset. , 1989, Toxicology and applied pharmacology.
[101] P Grasso,et al. Hepatic peroxisome proliferation in rodents and its significance for humans. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[102] I. Schultz,et al. The extent of dichloroacetate formation from trichloroethylene, chloral hydrate, trichloroacetate, and trichloroethanol in B6C3F1 mice. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.
[103] P O Droz,et al. Variability in biological monitoring of solvent exposure. I. Development of a population physiological model. , 1989, British journal of industrial medicine.
[104] R L Dedrick. Pharmacokinetic and pharmacodynamic considerations for chronic hemodialysis. , 1975, Kidney international. Supplement.
[105] A. Deangelo,et al. Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids. , 1989, Toxicology and applied pharmacology.
[106] H J Clewell,et al. Applying simulation modeling to problems in toxicology and risk assessment--a short perspective. , 1995, Toxicology and applied pharmacology.
[107] H J Clewell,et al. Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. , 1989, Toxicology and applied pharmacology.
[108] J. Opdam. Intra and interindividual variability in the kinetics of a poorly and highly metabolising solvent. , 1989, British journal of industrial medicine.
[109] C B Frederick,et al. Limiting the uncertainty in risk assessment by the development of physiologically based pharmacokinetic and pharmacodynamic models. , 1993, Toxicology letters.
[110] T. Lawlor,et al. Absence of mutagenic effects of sodium dichloroacetate. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[111] S. Curry,et al. Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses , 1991, Biopharmaceutics & drug disposition.
[112] R C Spear,et al. Modeling benzene pharmacokinetics across three sets of animal data: parametric sensitivity and risk implications. , 1991, Risk analysis : an official publication of the Society for Risk Analysis.
[113] H. Bolt. Pharmacokinetic factors and their implication in the induction of mouse liver tumors by halogenated hydrocarbons. , 1987, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.
[114] T. Nakajima,et al. Three forms of trichloroethylene-metabolizing enzymes in rat liver induced by ethanol, phenobarbital, and 3-methylcholanthrene. , 1990, Toxicology and applied pharmacology.
[115] NTP Carcinogenesis Studies of Trichloroethylene (Without Epichlorohydrin) (CAS No. 79-01-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). , 1990, National Toxicology Program technical report series.
[116] Timothy R. Gerrity,et al. Principles of route-to-route extrapolation for risk assessment : proceedings of the Workshops on Principles of Route-to-Route Extrapolation for Risk Assessment held March 19-21, 1990, in Hilton Head, South Carolina and July 10-11, 1990, in Durham, North Carolina , 1990 .
[117] F Y Bois,et al. Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics. , 2000, Environmental health perspectives.
[118] M. A. Pereira,et al. Carcinogenic activity of dichloroacetic acid and trichloroacetic acid in the liver of female B6C3F1 mice. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[119] M. A. Pereira,et al. Promotion by dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice. , 1996, Cancer letters.
[120] M S Prout,et al. Species differences in response to trichloroethylene. I. Pharmacokinetics in rats and mice. , 1985, Toxicology and applied pharmacology.
[121] P O Droz,et al. Variability in biological monitoring of organic solvent exposure. II. Application of a population physiological model. , 1989, British journal of industrial medicine.
[122] A. J. Gandolfi,et al. Chronic toxicity of S‐(trans‐1,2‐dichlorovinyl)‐L‐cysteine in mice , 1984, Journal of applied toxicology : JAT.
[123] J. Fisher,et al. Gastrointestinal absorption of xenobiotics in physiologically based pharmacokinetic models. A two-compartment description. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[124] S. Okuyama,et al. Ethanol-induced enhancement of trichloroethylene metabolism and hepatotoxicity: difference from the effect of phenobarbital. , 1988, Toxicology and applied pharmacology.
[125] P. Stacpoole. The pharmacology of dichloroacetate. , 1989, Metabolism: clinical and experimental.
[126] D. Stevens,et al. Acid-labile adducts to protein can be used as indicators of the cysteine S-conjugate pathway of trichloroethene metabolism. , 1995, Journal of toxicology and environmental health.
[127] C. Maltoni,et al. Long‐Term Carcinogenicity Bioassays on Trichloroethylene Administered by Inhalation to Sprague‐Dawley Rats and Swiss and B6C3F1 Mice , 1988, Annals of the New York Academy of Sciences.
[128] N. Vermeulen,et al. Mutagenicity and cytotoxicity of two regioisomeric mercapturic acids and cysteine S-conjugates of trichloroethylene , 2005, Archives of Toxicology.
[129] M E Andersen,et al. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse. , 1991, Toxicology and applied pharmacology.
[130] S H Khan,et al. Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[131] D. Stevens,et al. Haloacetate-induced oxidative damage to DNA in the liver of male B6C3F1 mice. , 1996, Toxicology.
[132] C. Elcombe,et al. Biochemical, histological, and ultrastructural changes in rat and mouse liver following the administration of trichloroethylene: possible relevance to species differences in hepatocarcinogenicity. , 1985, Toxicology and applied pharmacology.
[133] H J Clewell,et al. Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: examples with vinyl chloride and trichloroethylene. , 1995, Chemosphere.
[134] J. Brown,et al. Enhancement of the hepatotoxicity of chloroform in B6C3F1 mice by corn oil: implications for chloroform carcinogenesis. , 1986, Environmental health perspectives.
[135] H Tsuruta,et al. Inhalation carcinogenicity of trichloroethylene in mice and rats. , 1983, Industrial health.
[136] J. Styles,et al. Trichloroacetic acid: studies on uptake and effects on hepatic DNA and liver growth in mouse. , 1991, Carcinogenesis.
[137] P Fenner-Crisp,et al. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? , 1998, Regulatory toxicology and pharmacology : RTP.
[138] S. Curry,et al. Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate , 1985, Clinical pharmacology and therapeutics.
[139] G. Johanson,et al. Effects of consumption of ethanol on the biological monitoring of exposure to organic solvent vapours: a simulation study with trichloroethylene. , 1991, British journal of industrial medicine.
[140] C. Elcombe. Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment. , 1985, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.
[141] D. DeMarini,et al. Dichloroacetic acid and related compounds: induction of prophage in E. coli and mutagenicity and mutation spectra in Salmonella TA100. , 1994, Mutagenesis.
[142] P. Bonate,et al. Factors affecting species differences in the kinetics of metabolites of trichloroethylene. , 1995, Journal of toxicology and environmental health.
[143] I. Davidson,et al. Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. , 1991, Drug metabolism reviews.
[144] N. Lalwani,et al. Induction of hepatic peroxisome proliferation in nonrodent species, including primates. , 1984, The American journal of pathology.
[145] O. Axelson,et al. Updated and expanded Swedish cohort study on trichloroethylene and cancer risk. , 1994, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[146] A J Bailer,et al. The impact of exercise and intersubject variability on dose estimates for dichloromethane derived from a physiologically based pharmacokinetic model. , 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[147] L. Lash,et al. Mechanism of S-(1,2-dichlorovinyl)-L-cysteine- and S-(1,2-dichlorovinyl)-L-homocysteine-induced renal mitochondrial toxicity. , 1987, Molecular pharmacology.
[148] R W D'Souza,et al. Physiological Pharmacokinetic Models: Some Aspects of Theory, Practice and Potential , 1988, Toxicology and industrial health.
[149] J. Opdam. Respiratory input in inhalation experiments. , 1989, British journal of industrial medicine.
[150] H. Bartsch,et al. Comparison of the hydroxylation of benzo(a)pyrene with the metabolism of vinyl chloride, N-nitrosomorpholine, and N-nitroso-N'-methylpiperazine to mutagens by human and rat liver microsomal fractions. , 1980, Cancer research.
[151] P. Eacho,et al. Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and rhesus monkey hepatocytes. , 1990, Toxicology and applied pharmacology.
[152] J. Odum,et al. Perchloroethylene-induced rat kidney tumors: an investigation of the mechanisms involved and their relevance to humans. , 1990, Toxicology and applied pharmacology.
[153] M E Andersen,et al. Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling. , 1990, Toxicology and applied pharmacology.
[154] J. Larson,et al. Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. , 1992, Toxicology and applied pharmacology.
[155] H. Moch,et al. [Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis]. , 1999, Verhandlungen der Deutschen Gesellschaft fur Pathologie.
[156] H J Clewell,et al. Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. , 2001, The Science of the total environment.
[157] L. Rhomberg. Dose-response analyses of the carcinogenic effects of trichloroethylene in experimental animals. , 2000, Environmental health perspectives.
[158] S. Nasim,et al. Ras oncogene activation during hepatocarcinogenesis in B6C3F1 male mice by dichloroacetic and trichloroacetic acids. , 1995, Carcinogenesis.
[159] R. Kanamaru,et al. Association between Restriction Fragment Length Polymorphism of the Human Cytochrome P450IIE1 Gene and Susceptibility to Lung Cancer , 1991, Japanese journal of cancer research : Gann.
[160] H. Brauch,et al. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. , 1999, Journal of the National Cancer Institute.
[161] Julia S Kimbell,et al. Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[162] Richard D. Thomas. Dose-Route Extrapolations: Using Inhalation Toxicity Data to Set Drinking Water Limits , 1986 .
[163] H. Vainio,et al. A comparative study on the contribution of cytochrome P450 isozymes to metabolism of benzene, toluene and trichloroethylene in rat liver. , 1992, Biochemical pharmacology.
[164] D. Henschler,et al. Carcinogenicity study of trichloroethylene by longterm inhalation in three animal species , 1980, Archives of Toxicology.
[165] B. Allen,et al. Evaluation of uncertainty in input parameters to pharmacokinetic models and the resulting uncertainty in output. , 1989, Toxicology letters.
[166] H W Leung,et al. Development and utilization of physiologically based pharmacokinetic models for toxicological applications. , 1991, Journal of toxicology and environmental health.
[167] Ulrike Bernauer,et al. Biotransformation of trichloroethene: dose-dependent excretion of 2,2,2-trichloro-metabolites and mercapturic acids in rats and humans after inhalation , 1996, Archives of Toxicology.
[168] A. Blackburn,et al. Polymorphism- and species-dependent inactivation of glutathione transferase zeta by dichloroacetate. , 2000, Chemical research in toxicology.
[169] D. Casciano,et al. Mouse liver microsomal metabolism of chloral hydrate, trichloroacetic acid, and trichloroethanol leading to induction of lipid peroxidation via a free radical mechanism. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[170] I. S. Blagbrough,et al. Human renal C-S lyase: structure-activity relationships of cytosolic and mitochondrial enzymes. , 1990, Toxicology letters.
[171] D. Henschler,et al. Metabolism of trichloroethylene in man , 2004, Archives of Toxicology.
[172] A. Owens,et al. Absorption, excretion and metabolic fate of chloral hydrate and trichloroethanol. , 1954, Bulletin of the Johns Hopkins Hospital.
[173] D. Stevens,et al. Renal activation of trichloroethene and S-(1,2-dichlorovinyl)-L-cysteine and cell proliferative responses in the kidneys of F344 rats and B6C3F1 mice. , 1995, Journal of toxicology and environmental health.
[174] R. Snyder,et al. In vivo administration of dichloroacetic acid suppresses spontaneous apoptosis in murine hepatocytes. , 1995, Cancer research.
[175] R H Reitz,et al. Physiologically based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose, and dose route extrapolations. , 1988, Toxicology and applied pharmacology.
[176] R. Bull,et al. Differences in phenotype and cell replicative behavior of hepatic tumors induced by dichloroacetate (DCA) and trichloroacetate (TCA). , 1997, Toxicology and applied pharmacology.
[177] A. Steinberg,et al. Have animal data been used inappropriately to estimate risks to humans from environmental trichloroethylene? , 1993, Regulatory toxicology and pharmacology : RTP.
[178] R K Jain,et al. Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.
[179] W. Stott,et al. The pharmacokinetics and macromolecular interactions of trichloroethylene in mice and rats. , 1982, Toxicology and applied pharmacology.
[180] E. Lock. Studies on the mechanism of nephrotoxicity and nephrocarcinogenicity of halogenated alkenes. , 1988, Critical reviews in toxicology.
[181] S Kettle,et al. Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis , 1994, Human & experimental toxicology.
[182] A. Monster,et al. Pharmacokinetics of trichloroethylene in volunteers, influence of workload and exposure concentration , 1976, International archives of occupational and environmental health.
[183] Gary M Williams,et al. Dose-response relationships of hepatic acyl-CoA oxidase and catalase activity and livermitogenesis induced by the peroxisome proliferator ciprofibrate in C57BL6N and BALBc mice , 1992 .
[184] I. Schultz,et al. Effect of pre-treatment with dichloroacetic or trichloroacetic acid in drinking water on the pharmacokinetics of a subsequent challenge dose in B6C3F1 mice. , 1999, Chemico-biological interactions.
[185] D. Stevens,et al. Conversion of trichloroacetic acid to dichloroacetic acid in biological samples. , 1996, Journal of analytical toxicology.
[186] J. Reddy,et al. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. , 1983, Critical reviews in toxicology.
[187] J. Buben,et al. Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene: a dose-effect study. , 1985, Toxicology and applied pharmacology.
[188] T. Brüning,et al. Pathological excretion patterns of urinary proteins in renal cell cancer patients exposed to trichloroethylene. , 1999, Occupational medicine.
[189] W. Dekant,et al. Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2,2-trichlorovinyl)-L-cysteine formed by cysteine conjugate beta-lyase. , 1988, Chemical research in toxicology.
[190] J. Lipscomb,et al. Cytochrome P450-dependent metabolism of trichloroethylene: interindividual differences in humans. , 1997, Toxicology and applied pharmacology.
[191] Richard D. Thomas. Drinking Water and Health , 1986 .
[192] D. Wolf,et al. Acute hepatotoxic and nephrotoxic effects of chloroform in male F-344 rats and female B6C3F1 mice. , 1993, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[193] T. Green. Species differences in carcinogenicity: the role of metabolism in human risk evaluation. , 1990, Teratogenesis, carcinogenesis, and mutagenesis.
[194] J. N. Blancato,et al. Update to the health assessment document and addendum for dichloromethane (methylene chloride): pharmacokinetics, mechanism of action, and epidemiology. External review draft , 1987 .
[195] D. Wolf,et al. Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: comparison of administration by gavage in corn oil vs ad libitum in drinking water. , 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[196] R. Bull,et al. Dichloroacetic acid and trichloroacetic acid-induced DNA strand breaks are independent of peroxisome proliferation. , 1989, Toxicology.
[197] M. Metzler,et al. Absorption, elimination and metabolism of trichloroethylene: a quantitative comparison between rats and mice. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.
[198] D. Mayers,et al. Chloral hydrate disposition following single-dose administration to critically ill neonates and children. , 1991, Developmental pharmacology and therapeutics.
[199] A. Deangelo,et al. The role of hyperplastic nodules in dichloroacetic acid-induced hepatocarcinogenesis in B6C3F1 male mice. , 1991, Carcinogenesis.
[200] J. M. Christensen,et al. Urinary concentrations of trichloroacetic acid in Danish workers exposed to trichloroethylene, 1947-1985. , 2001, American journal of industrial medicine.
[201] K. Ivanetich,et al. Chlorinated ethylenes: their metabolism and effect on DNA repair in rat hepatocytes. , 1984, Carcinogenesis.
[202] D. Henschler,et al. Carcinogenicity study of trichloroethylene, with and without epoxide stabilizer, in mice , 2005, Journal of Cancer Research and Clinical Oncology.
[203] J. Blancato,et al. Metabolism, toxicity, and carcinogenicity of trichloroethylene. , 1989, Critical reviews in toxicology.
[204] E. Mariman,et al. The insulin–like growth factor type–2 receptor gene is imprinted in the mouse but not in humans , 1993, Nature Genetics.
[205] M. Ellis,et al. The role of glutathione conjugation in the development of kidney tumours in rats exposed to trichloroethylene. , 1997, Chemico-biological interactions.
[206] Brian A. Wong,et al. A 90-day chloroform inhalation study in F-344 rats: profile of toxicity and relevance to cancer studies. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[207] G. Olson,et al. Carcinogenicity of Chloral Hydrate Administered in Drinking Water to the Male F344/N Rat and Male B6C3F1 Mouse , 2000, Toxicologic pathology.
[208] Jirtle Rl. Liver tumor promotion: a process of natural selection. , 1995 .
[209] E. R. Garrett,et al. Pharmacokinetics of trichloroethanol and metabolites and interconversions among variously referenced pharmacokinetic parameters. , 1973, Journal of pharmaceutical sciences.
[210] Yu-Mei Tan,et al. Biologically motivated computational modeling of chloroform cytolethality and regenerative cellular proliferation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[211] J. H. Carter,et al. Immunohistochemical analysis of dichloroacetic acid (DCA)-induced hepatocarcinogenesis in male Fischer (F344) rats. , 1995, Cancer letters.
[212] H J Clewell,et al. Coupling of computer modeling with in vitro methodologies to reduce animal usage in toxicity testing. , 1993, Toxicology letters.
[213] E. Heseltine,et al. Dry cleaning, some solvents used in dry cleaning and other industrial chemicals. IARC meeting, Lyon, 7-14 February 1995. , 1995, Scandinavian journal of work, environment & health.
[214] J. Fisher,et al. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice. , 1999, Toxicology and applied pharmacology.
[215] M E Meek,et al. Lessons learned in applying the U.S. EPA proposed cancer guidelines to specific compounds. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[216] K T Bogen,et al. Pharmacokinetics for regulatory risk analysis: the case of trichloroethylene. , 1988, Regulatory toxicology and pharmacology : RTP.
[217] J W Fisher,et al. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. , 1997, Toxicology and applied pharmacology.
[218] J. Odum,et al. A mechanism for the development of Clara cell lesions in the mouse lung after exposure to trichloroethylene. , 1992, Chemico-biological interactions.
[219] G. Lucier,et al. Considerations concerning the murine hepatocarcinogenicity of selected chlorinated hydrocarbons. , 1995, Progress in clinical and biological research.
[220] J. Auwerx,et al. Alterations in Lipoprotein Metabolism in Peroxisome Proliferator-activated Receptor α-deficient Mice* , 1997, The Journal of Biological Chemistry.
[221] W. Dekant,et al. Enzymatic transformation of mercapturic acids derived from halogenated alkenes to reactive and mutagenic intermediates. , 1987, Biochemical pharmacology.
[222] H. Vainio,et al. Cytochrome P450-related differences between rats and mice in the metabolism of benzene, toluene and trichloroethylene in liver microsomes. , 1993, Biochemical pharmacology.
[223] G. Olson,et al. The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. , 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[224] M. Metzler,et al. Novel metabolites of trichloroethylene through dechlorination reactions in rats, mice and humans. , 1984, Biochemical pharmacology.
[225] R. T. Miller,et al. TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion. , 1995, Carcinogenesis.
[226] R J Bull,et al. Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. , 1990, Toxicology.
[227] T. Green,et al. Chloroethylenes: a mechanistic approach to human risk evaluation. , 1990, Annual review of pharmacology and toxicology.
[228] D. Savitz,et al. Magnetic Field Exposure and Neurodegenerative Disease Mortality among Electric Utility Workers , 1998, Epidemiology.
[229] R. Coulombe,et al. Pharmacokinetics in Risk Assessment , 1996 .
[230] D. H. Taylor,et al. Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. , 1990, Toxicology and applied pharmacology.
[231] D. Waxman,et al. Activation of peroxisome proliferator-activated receptors by chlorinated hydrocarbons and endogenous steroids. , 1998, Environmental health perspectives.
[232] F Y Bois,et al. Precision and sensitivity of pharmacokinetic models for cancer risk assessment: tetrachloroethylene in mice, rats, and humans. , 1990, Toxicology and applied pharmacology.
[233] R. Hertzberg,et al. A new method for determining allowable daily intakes. , 1986, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[234] K. H. Vyas,et al. Biological disposition of sodium dichloroacetate in animals and humans after intravenous administration. , 1980, Journal of pharmaceutical sciences.
[235] F Y Bois,et al. Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics. , 2000, Environmental health perspectives.
[236] B. Thrall,et al. Effects of dichloroacetate (DCA) on serum insulin levels and insulin-controlled signaling proteins in livers of male B6C3F1 mice. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[237] M. Metzler,et al. Identification of S-1,2-dichlorovinyl-N-acetyl-cysteine as a urinary metabolite of trichloroethylene: a possible explanation for its nephrocarcinogenicity in male rats. , 1986, Biochemical pharmacology.
[238] P. Newberne,et al. Effects of dietary fat on hepatic mixed-function oxidases and hepatocellular carcinoma induced by aflatoxin B1 in rats. , 1979, Cancer research.
[239] J. Gallo,et al. Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats. , 1991, Toxicology and applied pharmacology.
[240] B. Gonthier,et al. In-vitro spin-trapping of free radicals produced during trichloroethylene and diethylether metabolism. , 1989, Toxicology letters.
[241] H J Clewell,et al. Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE). , 1993, Toxicology letters.
[242] G. Williams,et al. Butylated hydroxyanisole mechanistic data and risk assessment: conditional species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion. , 1996, Pharmacology & therapeutics.
[243] Rory B. Conolly,et al. Physiologically Based Pharmacokinetic Model of the Metabolism of Trichloroethylene by an Isolated Ventilated Perfused Lung , 1990 .
[244] H J Clewell,et al. Incorporation of pharmacokinetics in noncancer risk assessment: example with chloropentafluorobenzene. , 1994, Risk analysis : an official publication of the Society for Risk Analysis.
[245] M E Hurtt,et al. Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism. , 1992, Toxicology and applied pharmacology.
[246] G. Olson,et al. The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat. , 1996, Toxicology.
[247] S. Bondy,et al. Ethanol toxicity and oxidative stress. , 1992, Toxicology letters.
[248] M Younes,et al. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.
[249] D E Marano,et al. Exposure assessment for a large epidemiological study of aircraft manufacturing workers. , 2000, Applied occupational and environmental hygiene.
[250] K. Hemminki,et al. Cancer Incidence among Finnish Workers Exposed to Halogenated Hydrocarbons , 1995 .
[251] Kannan Krishnan,et al. Incorporation of Pharmacokinetic and Pharmacodynamic Data into Risk Assessments , 2004, Toxicology mechanisms and methods.
[252] M. Kelsh,et al. Mortality of Aerospace Workers Exposed to Trichloroethylene , 1998, Epidemiology.
[253] A Sato,et al. The effect of environmental factors on the pharmacokinetic behaviour of organic solvent vapours. , 1991, The Annals of occupational hygiene.
[254] G. Johanson,et al. A simulation study of physiological factors affecting pharmacokinetic behaviour of organic solvent vapours. , 1991, British journal of industrial medicine.
[255] G. L. Kedderis,et al. The role of regenerative cell proliferation in chloroform-induced cancer. , 1995, Toxicology letters.
[256] D. Stevens,et al. Enterohepatic recirculation of trichloroethanol glucuronide as a significant source of trichloroacetic acid. Metabolites of trichloroethylene. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[257] W. Dekant,et al. Biosynthesis and biotransformation of glutathione S-conjugates to toxic metabolites. , 1988, Critical reviews in toxicology.